Navigation Links
Echo Therapeutics Reports Symphony™ tCGM System Ahead of Schedule
Date:2/17/2011

FRANKLIN, Mass., Feb. 17, 2011 /PRNewswire/ -- Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing the Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude™ SkinPrep System for transdermal drug delivery, announced that development of the commercially ready Symphony tCGM System is ahead of schedule.  The company said that the system will be ready for demonstration in the second quarter and it will be used in a clinical trial shortly thereafter, replacing the prototype used in earlier clinical trials.  

Echo said it anticipates that upon completion of the development work no further changes will be made to the Symphony tCGM System, and that the device will be the one used for sale, subject to positive clinical studies and FDA market clearance of the product.  The addressable market for needle-free, continuous wireless glucose monitoring in the hospital critical care setting exceeds $1 billion annually and the global glucose monitoring market exceeds $12 billion annually.

"With the successful completion of our recent financing we now have sufficient capital to accelerate the product development work of our Symphony tCGM System," said Patrick T. Mooney, M.D., Chairman and CEO of Echo Therapeutics.  "We are now prepared to complete our final development work and clinical validation.  This next generation Symphony device incorporates substantial improvements beyond the prototype used in earlier studies and we look forward to validating those improvements in clinical testing."  

The Symphony tCGM System incorporates Echo's proprietary Prelude SkinPrep System, with a noninvasive wireless biosensor and a wireless monitor or handheld device for needle-free, continuous monitoring of glucose levels.  

About Echo TherapeuticsEc
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
2. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
3. Echo Therapeutics Announces Appointments to Board of Directors
4. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
5. Cell Therapeutics, Inc. (CTI) to Report Fourth Quarter and Year-End 2010 Financial Results on February 16
6. Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics
7. Amicus Therapeutics Initiates Phase 2 Clinical Trial Evaluating Amigal™ Co-administered with Enzyme Replacement Therapy
8. Prime Therapeutics President and CEO Eric Elliott Presents Keynote Address at 2011 PCMA Managed Markets Educational Forum
9. NewCardio Study of QTinno Accuracy Selected for Presentation at the National Scientific Meeting of the American Society of Clinical Pharmacology and Therapeutics
10. DSM and NKT Therapeutics Sign Contract for Lead Product Development and Manufacture
11. JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015  Vivex Biomedical, Inc., ... technology, and biocellular products, announced today that it hired ... Officer of UMTB Biomedical, Inc.   Vivex Biomedical formed UMTB ... of Miami Tissue Bank (UMTB) in November 2014. UMTB ... Mr. Barnes is a twenty-five year veteran of ...
(Date:3/2/2015)...   Polymedco is committed to supporting efforts to get ... we are offering all existing customers complimentary CRC awareness ... – to be hung in patient rooms and in ... Stand – to be placed in patient seating areas ... on/in patient charts as a reminder to discuss patient,s ...
(Date:3/2/2015)... N.J. , March 2, 2015  Champions Oncology, ... of advanced technology solutions and services to personalize the ... 30 day extension on the $2 million convertible promissory ... December 1, 2014.  Dr. David ... "Champions continues to benefit from the confidence and commitment ...
Breaking Medicine Technology:Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 2Vivex Biomedical, Inc. Announces New Chief Operating Officer of Tissue Bank 3Polymedco CDP, LLC. Promotes March as Colorectal Cancer Awareness Month 2Champions Oncology Extends Convertible Debt Financing 2Champions Oncology Extends Convertible Debt Financing 3
... and PARIS , July 19 Corgenix Medical Corporation ... kits, and the ELITech Group, a Paris, France -based, privately held ... and reagents, today announced a broad strategic alliance. Terms of the agreement ... ...
... , ZURICH , July 19, 2010 ... - an,observational study designed to investigate the effects of modern insulins in,the management of ... Spanning ... be the world,s largest observational study,in insulin therapy. , ...
Cached Medicine Technology:Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 2Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 3Corgenix Medical Corp. and the ELITech Group Establish Strategic Alliance 4World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 2World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 3
(Date:3/2/2015)... Cutler Integrative Medicine a leader in bringing innovative naturopathic ... to bring about self-renewal. A 30 day detox is ... cleaning house. According to Dr. Cutler, expert in ... environmental toxins like heavy metals, people’s food now becoming ... levels, we all have a level of toxic burden. ...
(Date:3/2/2015)... A cocaine snorting Oscar statue in ... nip slip or scathing scuffle. A new take on ... streets of Hollywood as Paper Jesus’ rendition of the ... substance abuse in Hollywood. The Oscar statue is depicted ... stance on the travails of drug addiction in Hollywood. ...
(Date:3/2/2015)... Clearwater, FL (PRWEB) March 02, 2015 ... comply with Title VI of the Civil Rights Act, ... (LEP) and hearing loss are bringing light to the ... Bureau statistics reveal that nearly 1 in 20 U.S. ... 1 in 10 in some major cities.(1) Stratus ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In ... in Construction Week (March 1-7, sponsored by the National ... Women’s History Month, Robins & Morton is recognizing several ... and the construction industry as a whole. From the ... of roles in between, each woman has a story ...
(Date:3/2/2015)... March 02, 2015 Over the last ... among leading vendors seeking to expand their geographic presence ... is expected to reach $6.2 billion by 2019 at ... America including the U.S. and Canada and a major ... However developing regions such as Asia-Pacific including China and ...
Breaking Medicine News(10 mins):Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 2Health News:Oscar Statue Snorting Cocaine Catches All Eyes in Hollywood, Ca 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 2Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 3Health News:Stratus Video Addresses Inadequate Language Interpreting for 2.4 Million U.S. Children 4Health News:Robins & Morton Recognizes Women In Construction 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3
... Aug. 28, 2007 Dietary restrictions or other ... transplants more effective, UT Southwestern Medical Center researchers report. ... pancreatic islet cells transplanted into the liver fail not ... overexposure to toxic fats that are synthesized by the ...
... be available an open question, researcher says , , MONDAY, ... cardiac arrest while on school grounds, it makes the evening ... property is rare, and most of the victims are adults, ... service calls in the Seattle area, researchers found that faculty ...
... spend part of the Labor Day weekend complaining about their ... their jobs, a new University of Chicago study shows. ... with workers over 65 among the most satisfied. The ... 1972 and 2006 said they were satisfied at their jobs, ...
... A landmark study by University of Western Sydney researchers ... suffer fewer fractures and enjoy a better quality of ... calcium or calcium and vitamin D supplements, conducted by ... been published this week in the prestigious international medical ...
... survival, functioning may have been solved in rat experiments ... rats show that human embryonic stem cells can repair ... progression of heart failure. , Using stem cells to ... so far it has been fraught with problems. ...
... ears: Be sensible to avoid skin irritation , FRIDAY, Aug. ... that it,s almost like an addiction. , "For many people, it ... they,ve become so used to their lips having more moisture content ... at Baylor Medical Center in Garland, Texas, said in a prepared ...
Cached Medicine News:Health News:Circulating fats kill transplanted pancreas cells, study shows 2Health News:Heart Attacks at School Involve More Adults Than Kids 2Health News:Heart Attacks at School Involve More Adults Than Kids 3Health News:Despite grumbling, most Americans say they are happy at work 2Health News:International study strengthens case for daily calcium pill 2Health News:Embryonic Stem Cells Repair Human Heart 2Health News:Embryonic Stem Cells Repair Human Heart 3